Cargando…

Propranolol for Vascular Anomalies: Efficacy and Complications in Pediatric Patients

CONTEXT: Congenital vascular anomalies are classically subdivided into vascular tumors and vascular malformations. The role of propranolol in the regression of infantile hemangioma (IH), a vascular tumor, is well establishe. AIMS: This study aimed to analyze the therapeutic efficacy and complication...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gupta, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305951/ https://www.ncbi.nlm.nih.gov/pubmed/37389387 http://dx.doi.org/10.4103/jiaps.jiaps_117_22

Ejemplares similares

Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports)
por: Cîrstoveanu, Cătălin, et al.
Publicado: (2021)

Propranolol for the treatment of vascular sarcomas
por: Wagner, Michael J, et al.
Publicado: (2018)

Oral Propranolol for Treatment of Pediatric Capillary Hemangiomas
por: Aletaha, Maryam, et al.
Publicado: (2012)

EFFICACY OF PROPRANOLOL ON SCHIZOPHRENIC THOUGHT DISORDER
por: Sethi, B. B., et al.
Publicado: (1981)

Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development
por: Giese, Rachel A., et al.
Publicado: (2021)

L-carnitine versus Propranolol for pediatric migraine prophylaxis
por: AMINI, Laya, et al.
Publicado: (2021)

Venous Thromboembolism in Pediatric Vascular Anomalies
por: Nakano, Taizo A., et al.
Publicado: (2017)

Pediatric vascular anomalies with airway compromise
por: Gorostidi, François, et al.
Publicado: (2022)

A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
por: Eghbali, Aziz, et al.
Publicado: (2017)

Clinical course of pediatric large vascular anomalies located in the extremities
por: Oktay, Burcu Kılınç, et al.
Publicado: (2021)

The therapeutic efficacy of propranolol in children with recurrent primary epistaxis
por: Bjelakovic, Bojko, et al.
Publicado: (2013)

Propranolol attenuates factors affecting hypermetabolism in pediatric burn patients
por: Norbury, W
Publicado: (2007)

The Effect of Oral Propranolol versus Oral Corticosteroids in Management of Pediatric Hemangiomas
por: Ali, Adil, et al.
Publicado: (2018)

Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients
por: Guillory, Ashley N., et al.
Publicado: (2017)

Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence
por: Xiao, Qiang, et al.
Publicado: (2013)

Oral Propranolol in the Treatment of Ulcerated Bleeding Scrotal Arteriovenous Malformation
por: Singh, Gurmeet, et al.
Publicado: (2020)

Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma
por: Takechi, Tomoki, et al.
Publicado: (2018)

The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
por: Cuesta, Angel M., et al.
Publicado: (2022)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children
por: Hassan, Basheir A., et al.
Publicado: (2014)

Evaluation of Effect of Propranolol on Serum Vascular Endothelial Growth Factor and Tissue Inhibitor of Metalloproteinase-2 Levels in Infantile Hemangioma
por: Pandey, Anand, et al.
Publicado: (2020)

Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety
por: Razafindrazoto, Chantelli Iamblaudiot, et al.
Publicado: (2022)

Successful Treatment of Mild Pediatric Kasabach-Merritt Phenomenon with Propranolol Monotherapy
por: Choeyprasert, Worawut, et al.
Publicado: (2014)

The efficacy and duration of treatment with propranolol in children with cyclic vomiting syndrome in southern Iran
por: Haghighat, Mahmoud, et al.
Publicado: (2017)

Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis
por: Rezayat, Kambiz Akhavan, et al.
Publicado: (2017)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

In Vitro Sensitivity of Leukemia Cells to Propranolol
por: Hajighasemi, Fatemeh, et al.
Publicado: (2009)

Monitoring oral propranolol for infantile hemangiomata
por: Bar, Jonathan, et al.
Publicado: (2022)

3D CT cinematic rendering of pediatric thoracic vascular anomalies
por: Recht, Hannah S., et al.
Publicado: (2023)

Cardiac anomalies in pediatric patients with pectus excavatum
por: Acipayam, Ahmet, et al.
Publicado: (2023)

Propranolol for Infantile Haemangiomas: Experience from a Tertiary Center
por: Pandey, Vaibhav, et al.
Publicado: (2014)

The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding
por: Je, Dongmo, et al.
Publicado: (2014)

Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial
por: Tchivileva, Inna E, et al.
Publicado: (2021)

Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Clinical Approaches to Vascular Anomalies of the Lip
por: Ryu, Jeong Yeop, et al.
Publicado: (2015)

Impact of Vascular Anomalies on Pancreatoduodenectomy Procedure
por: Mansour, Subhi, et al.
Publicado: (2021)

Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma
por: Castaneda, Saul, et al.
Publicado: (2015)

Propranolol therapy in a case of capillary hemangioma
por: Vohra, Vishal, et al.
Publicado: (2015)

Visual Outcomes in Pediatric Patients with Peters Anomaly
por: Fouzdar-Jain, Samiksha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9i3phk9mqjie1jfqnbbg7ba7v